Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Wound Infection: later-stage trial registry

A small indexed set (11 trials) with no open enrollment listed right now.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · none currently recruiting · #1,577 of 28,707 conditions by registered trial count

Wound Infection: 11 US clinical trials tracked, none currently recruiting.

Wound Infection is the subject of 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 6 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Melinta Therapeutics, running 2 of these trials.

Enrollment posture brief

Registry condition wound-infection

OPEN 0 | RECR 0% | LATE 6 | EARLY 2 | RANK #1577 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Pancreatitis81.8%Acute Stroke45.5%Acquired Brain Injury36.4%Acute Lung Injury9.1%Wound Infection (this)0%
Open-enrollment share among volume-matched conditions near Wound Infection

Wound Infection has no open enrollment in this registry pull (11 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Wound Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Wound Infection is recruiting below its size-band peers.

    0 of 11 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Wound Infection research.

    Melinta Therapeutics accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Typical Wound Infection enrolment sits around 125 participants.

    Median target enrolment is 125 among the 11 trials that report a genuine target (sentinel values excluded). 3 of those (27.3%) plan for fewer than 100 participants.

  4. Wound Infection research is mostly interventional.

    11 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 34Phase 42

Indexed trials (enrollment closed)

11 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 3 600 participants

Tobramycin Injection to Prevent Infection in Open Fractures

Massachusetts General Hospital

NCT04964947

COMPLETED Phase 3 1,019 participants

Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection

Melinta Therapeutics

NCT01252732

COMPLETED Phase 3 968 participants

Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)

Melinta Therapeutics

NCT01252719

COMPLETED Phase 3 573 participants

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Durata Therapeutics Inc., an affiliate of Allergan

NCT01339091

COMPLETED NA 233 participants

Randomized Trial to Assess PO Versus IV Antibiotics

Major Extremity Trauma Research Consortium

NCT01714596

COMPLETED NA 125 participants

A Randomized Trial of Ostomy Closure Techniques

University of Minnesota

NCT01713452

COMPLETED Phase 2 105 participants

A Study to Evaluate a Quality Improvement Intervention to Reduce Wound Separation Rates in Obese Gynecologic Oncology Service Patients Undergoing Abdominal Surgery

Washington University School of Medicine

NCT02071251

COMPLETED Phase 4 100 participants

Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation

Georgetown University

NCT01939145

COMPLETED Phase 4 23 participants

Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery

Michael Stitely

NCT01755026

COMPLETED NA 21 participants

Activated Carbon Interphase Effect on Biofilm and Total Bacterial Load

Brock Liden, DPM

NCT03461783

COMPLETED Phase 1 16 participants

Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections

Hartford Hospital

NCT02620774

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 4
Phase 4 2

Named interventions

Most-linked intervention names on Wound Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

IV Vancomycin Drug
2 trials
Single-Dose IV Oritavancin Diphosphate Drug
2 trials
PO versus IV antibiotics Route of administration evaluation Other
1 trials
Vancomycin / Linezolid Drug
1 trials
Primary closure Procedure
1 trials
Purse string closure Procedure
1 trials
cefazolin Drug
1 trials
Prospective wound complication protocol Procedure
1 trials

US sites by state

Facility locations filed on Wound Infection trials. A trial with sites in several states counts in each.

California 4 trials
Tennessee 2 trials
Ohio 2 trials
Missouri 2 trials
Minnesota 2 trials
Massachusetts 2 trials
West Virginia 1 trials
Virginia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Wound Infection page

11 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Wound Infection trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Melinta Therapeutics sponsors the most Wound Infection trials on record, review their full trial history before evaluating a specific study. See Melinta Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Wound Infection condition card totals 11 registered trials; most-linked intervention IV Vancomycin; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.